Shopping Cart 0
Cart Subtotal
USD 0

Inovio Pharmaceuticals Inc (INO) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Inovio Pharmaceuticals Inc (INO)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Inovio Pharmaceuticals Inc (Inovio) is a biotechnology company that focuses on developing a portfolio of DNA immunotherapies and vaccines for the treatment and prevention of various cancers and infectious diseases. The company develops products based on its core SynCon DNA plasmid technology and electroporation delivery technology. It is advancing a preclinical and clinical stage product pipeline to fight cancers of the cervix, prostate, breast, bladder, head and neck, lung, and pancreas; and to protect against and eliminate infectious diseases such as HIV, hepatitis, Ebola, Zika virus and Middle East respiratory syndrome (MERS). Inovio is headquartered in Plymouth Meeting, Pennsylvania, the US.

Inovio Pharmaceuticals Inc Key Recent Developments

May 31,2018: Inovio CEO to Speak on Viral Epidemic Preparedness Panel at BIO International Convention

May 24,2018: Inovio Boosts Leadership Focused on Partnership and Grant Funding By Appointing Two New VPs for Business Development and R&D

May 09,2018: Inovio Pharmaceuticals Reports 2018 First Quarter Financial Results

Mar 14,2018: Inovio Pharmaceuticals Reports 2017 Fourth Quarter and Year End Financial Results

Feb 12,2018: Inovio and The Wistar Institute Receive More Than USD4.6 Million in R&D Funding to Advance Vaccines Against Tuberculosis & Malaria

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

Inovio Pharmaceuticals Inc-Key Facts 6

Inovio Pharmaceuticals Inc-Key Employees 7

Inovio Pharmaceuticals Inc-Key Employee Biographies 9

Inovio Pharmaceuticals Inc-Major Products and Services 10

Inovio Pharmaceuticals Inc-History 11

Inovio Pharmaceuticals Inc-Company Statement 16

Inovio Pharmaceuticals Inc-Locations And Subsidiaries 18

Head Office 18

Other Locations & Subsidiaries 18

Section 2-Company Analysis 19

Company Overview 19

Inovio Pharmaceuticals Inc-Business Description 20

Inovio Pharmaceuticals Inc-Corporate Strategy 21

Inovio Pharmaceuticals Inc-SWOT Analysis 22

SWOT Analysis-Overview 22

Inovio Pharmaceuticals Inc-Strengths 22

Inovio Pharmaceuticals Inc-Weaknesses 23

Inovio Pharmaceuticals Inc-Opportunities 24

Inovio Pharmaceuticals Inc-Threats 25

Inovio Pharmaceuticals Inc-Key Competitors 26

Section 3-Company Financial Ratios 27

Financial Ratios-Capital Market Ratios 27

Financial Ratios-Annual Ratios 28

Performance Chart 30

Financial Performance 30

Financial Ratios-Interim Ratios 31

Financial Ratios-Ratio Charts 32

Section 4-Company's Lifesciences Financial Deals and Alliances 33

Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 33

Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 34

Inovio Pharmaceuticals Inc, Recent Deals Summary 35

Section 5-Company's Recent Developments 36

May 31, 2018: Inovio CEO to Speak on Viral Epidemic Preparedness Panel at BIO International Convention 36

May 24, 2018: Inovio Boosts Leadership Focused on Partnership and Grant Funding By Appointing Two New VPs for Business Development and R&D 37

May 09, 2018: Inovio Pharmaceuticals Reports 2018 First Quarter Financial Results 38

Mar 14, 2018: Inovio Pharmaceuticals Reports 2017 Fourth Quarter and Year End Financial Results 40

Feb 12, 2018: Inovio and The Wistar Institute Receive More Than USD4.6 Million in R&D Funding to Advance Vaccines Against Tuberculosis & Malaria 43

Jan 22, 2018: Inovio Pharmaceuticals' Published Universal Flu Vaccine Data Demonstrates Protective Responses Against All Major, Lethal H1N1 Influenza Viruses From the Last 100 Years in Animal Models 44

Jan 18, 2018: The Wistar Institute Awarded More Than USD1.4 Million to Create a Malaria Vaccine Through Synthetic DNA-Based Technology 45

Dec 11, 2017: Inovio Pharmaceuticals Promotes Dr. Laurent Humeau to Senior Vice President, Research & Development 46

Dec 06, 2017: Inovio Pharmaceuticals Appoints Wendy Yarno To its Board of Directors 47

Nov 08, 2017: Inovio Pharmaceuticals Reports 2017 Third Quarter Financial Results 48

Section 6-Appendix 51

Methodology 51

Ratio Definitions 51

About GlobalData 55

Contact Us 55

Disclaimer 55


List Of Figure

List of Figures

Inovio Pharmaceuticals Inc, Performance Chart (2013-2017) 30

Inovio Pharmaceuticals Inc, Ratio Charts 32

Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 33

Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 34


List Of Table

List of Tables

Inovio Pharmaceuticals Inc, Key Facts 6

Inovio Pharmaceuticals Inc, Key Employees 7

Inovio Pharmaceuticals Inc, Key Employee Biographies 9

Inovio Pharmaceuticals Inc, Major Products and Services 10

Inovio Pharmaceuticals Inc, History 11

Inovio Pharmaceuticals Inc, Subsidiaries 18

Inovio Pharmaceuticals Inc, Key Competitors 26

Inovio Pharmaceuticals Inc, Ratios based on current share price 27

Inovio Pharmaceuticals Inc, Annual Ratios 28

Inovio Pharmaceuticals Inc, Annual Ratios (Cont...1) 29

Inovio Pharmaceuticals Inc, Interim Ratios 31

Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 33

Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 34

Inovio Pharmaceuticals Inc, Recent Deals Summary 35

Currency Codes 51

Capital Market Ratios 51

Equity Ratios 52

Profitability Ratios 52

Cost Ratios 53

Liquidity Ratios 53

Leverage Ratios 54

Efficiency Ratios 54

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Inovio Pharmaceuticals Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Sanofi

Novavax Inc

Novartis Vaccines and Diagnostics Inc

MedImmune LLC

Janssen Pharmaceuticals Inc

GlaxoSmithKline Plc

BioNTech AG

Advaxis Inc